Key Proteo, Inc.
Biotechnology company · Seattle, Washington, United States
Key Proteo, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2023.
Key Proteo at a glance
What does Key Proteo do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $3 million sold (2023).
Frequently asked questions about Key Proteo
Where is Key Proteo headquartered?
Key Proteo, Inc. is headquartered in Seattle, Washington, United States.
What does Key Proteo do?
Key Proteo, Inc. is a biotechnology company.
When was Key Proteo founded?
The earliest incorporation on record for Key Proteo, Inc. is in 2019, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences